Quick Answer
NEOGENOMICS INC reported Cash And Cash Equivalents At Carrying Value of $159.62 million for the year ending 2025.
- NEOGENOMICS INC showed a decrease of -56.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $2.53 million | Q3 2011: $2.65 million | Q1 2012: $2.76 million | Q2 2012: $2.57 million | Q3 2012: $2.04 million | Q1 2013: $4.63 million | Q2 2013: $4.64 million | Q3 2013: $4.93 million | Q1 2014: $5.39 million | Q2 2014: $5.02 million | Q3 2014: $34.37 million | Q1 2015: $31.25 million | Q2 2015: $32.95 million | Q3 2015: $33.97 million | Q1 2016: $19.26 million | Q2 2016: $21.79 million | Q3 2016: $28.94 million | Q1 2017: $11.04 million | Q2 2017: $10.93 million | Q3 2017: $12.21 million | Q1 2018: $15.17 million | Q2 2018: $9.44 million | Q3 2018: $118.44 million | Q1 2019: $13.20 million | Q2 2019: $167.44 million | Q3 2019: $178.89 million | Q1 2020: $86.25 million | Q2 2020: $295.28 million | Q3 2020: $233.23 million | Q1 2021: $611.97 million | Q2 2021: $368.80 million | Q3 2021: $340.57 million | Q1 2022: $305.90 million | Q2 2022: $283.64 million | Q3 2022: $266.13 million | Q1 2023: $275.61 million | Q2 2023: $289.07 million | Q3 2023: $306.24 million | Q1 2024: $331.91 million | Q2 2024: $355.09 million | Q3 2024: $361.99 million | Q1 2025: $346.19 million | Q2 2025: $154.72 million | Q3 2025: $164.12 million.
- Over the full 17 years of available data (2009 to 2025), NEOGENOMICS INC's Cash And Cash Equivalents At Carrying Value has grown by 9,686.5%.
- Historical annual values: Fiscal year 2025: $159.62 million | Fiscal year 2024: $367.01 million | Fiscal year 2023: $342.49 million | Fiscal year 2022: $263.18 million | Fiscal year 2021: $316.83 million | Fiscal year 2020: $228.71 million | Fiscal year 2019: $173.02 million | Fiscal year 2018: $9.81 million | Fiscal year 2017: $12.82 million | Fiscal year 2016: $12.53 million | Fiscal year 2015: $23.42 million | Fiscal year 2014: $33.69 million | Fiscal year 2013: $4.83 million | Fiscal year 2012: $1.87 million | Fiscal year 2011: $2.63 million | Fiscal year 2010: $1.10 million | Fiscal year 2009: $1.63 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: